Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000618219 | SCV000737295 | uncertain significance | Cardiovascular phenotype | 2017-07-31 | criteria provided, single submitter | clinical testing | The p.R22300C variant (also known as c.66898C>T), located in coding exon 166 of the TTN gene, results from a C to T substitution at nucleotide position 66898. The arginine at codon 22300 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Eurofins Ntd Llc |
RCV000730619 | SCV000858370 | uncertain significance | not provided | 2017-12-11 | criteria provided, single submitter | clinical testing |